These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

759 related articles for article (PubMed ID: 15496527)

  • 1. Biopharmaceuticals derived from genetically modified plants.
    Goldstein DA; Thomas JA
    QJM; 2004 Nov; 97(11):705-16. PubMed ID: 15496527
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transgenic plants as factories for biopharmaceuticals.
    Giddings G; Allison G; Brooks D; Carter A
    Nat Biotechnol; 2000 Nov; 18(11):1151-5. PubMed ID: 11062432
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plant-based production of biopharmaceuticals.
    Fischer R; Stoger E; Schillberg S; Christou P; Twyman RM
    Curr Opin Plant Biol; 2004 Apr; 7(2):152-8. PubMed ID: 15003215
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Advances in plant molecular farming.
    Obembe OO; Popoola JO; Leelavathi S; Reddy SV
    Biotechnol Adv; 2011; 29(2):210-22. PubMed ID: 21115109
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Plant-based production of recombinant cytokines].
    Góra-Sochacka A; Redkiewicz P; Napiórkowska B; Sirko A
    Postepy Biochem; 2009; 55(1):85-94. PubMed ID: 19514469
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Safety and nutritional assessment of GM plants and derived food and feed: the role of animal feeding trials.
    EFSA GMO Panel Working Group on Animal Feeding Trials
    Food Chem Toxicol; 2008 Mar; 46 Suppl 1():S2-70. PubMed ID: 18328408
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plant-derived vaccines and other therapeutics produced in contained systems.
    Franconi R; Demurtas OC; Massa S
    Expert Rev Vaccines; 2010 Aug; 9(8):877-92. PubMed ID: 20673011
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plant-made pharmaceuticals: leading products and production platforms.
    Paul M; Ma JK
    Biotechnol Appl Biochem; 2011; 58(1):58-67. PubMed ID: 21446960
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plant-made pharmaceuticals for the prevention and treatment of autoimmune diseases: where are we?
    Avesani L; Bortesi L; Santi L; Falorni A; Pezzotti M
    Expert Rev Vaccines; 2010 Aug; 9(8):957-69. PubMed ID: 20673017
    [TBL] [Abstract][Full Text] [Related]  

  • 10. From Neanderthal to nanobiotech: from plant potions to pharming with plant factories.
    Sourrouille C; Marshall B; Liénard D; Faye L
    Methods Mol Biol; 2009; 483():1-23. PubMed ID: 19183890
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bioreactor technology: a novel industrial tool for high-tech production of bioactive molecules and biopharmaceuticals from plant roots.
    Sivakumar G
    Biotechnol J; 2006 Dec; 1(12):1419-27. PubMed ID: 17136730
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plants as bioreactors for biopharmaceuticals: regulatory considerations.
    Miele L
    Trends Biotechnol; 1997 Feb; 15(2):45-50. PubMed ID: 9081298
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plant-made therapeutics: an emerging platform in South Africa.
    Rybicki EP; Chikwamba R; Koch M; Rhodes JI; Groenewald JH
    Biotechnol Adv; 2012; 30(2):449-59. PubMed ID: 21839824
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Challenges in therapeutic glycoprotein production.
    Sethuraman N; Stadheim TA
    Curr Opin Biotechnol; 2006 Aug; 17(4):341-6. PubMed ID: 16828275
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antibody production by molecular farming in plants.
    Fischer R; Hoffmann K; Schillberg S; Emans N
    J Biol Regul Homeost Agents; 2000; 14(2):83-92. PubMed ID: 10841283
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Therapeutic antibody production technologies: molecules, applications, expression and purification.
    Humphreys DP; Glover DJ
    Curr Opin Drug Discov Devel; 2001 Mar; 4(2):172-85. PubMed ID: 11378956
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transient expression systems for plant-derived biopharmaceuticals.
    Komarova TV; Baschieri S; Donini M; Marusic C; Benvenuto E; Dorokhov YL
    Expert Rev Vaccines; 2010 Aug; 9(8):859-76. PubMed ID: 20673010
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Opportunities for recombinant antigen and antibody expression in transgenic plants--technology assessment.
    Schillberg S; Twyman RM; Fischer R
    Vaccine; 2005 Mar; 23(15):1764-9. PubMed ID: 15734038
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Seed-based expression systems for plant molecular farming.
    Boothe J; Nykiforuk C; Shen Y; Zaplachinski S; Szarka S; Kuhlman P; Murray E; Morck D; Moloney MM
    Plant Biotechnol J; 2010 Jun; 8(5):588-606. PubMed ID: 20500681
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Downstream processing of recombinant proteins from transgenic feedstock.
    Nikolov ZL; Woodard SL
    Curr Opin Biotechnol; 2004 Oct; 15(5):479-86. PubMed ID: 15464381
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 38.